Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
EWTX | US
0.35
1.12%
Healthcare
Biotechnology
30/06/2024
24/04/2026
31.58
31.40
32.03
30.93
Edgewise Therapeutics Inc. a biopharmaceutical company discovers develops and commercializes therapies for the treatment of muscle disorders. Its lead product candidate EDG-5506 an orally administered small molecule that is in Phase II clinical trials designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company also develops EDG-7500 a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders. In addition it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. The Company was incorporated in 2017 and is headquartered in Boulder Colorado.
View LessStrength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
High 6-Month Volatility (>65%)
Midcap (2B - 10B USD)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
41.6%1 month
42.6%3 months
44.1%6 months
81.1%-
-
6.52
0.01
0.01
-2.60
-
-
-134.29M
2.96B
2.96B
-
-
-
-
-28.20
5.47
14.62
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
4.07
Range1M
5.29
Range3M
8.18
Rel. volume
1.22
Price X volume
29.28M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| iShares $ Corp Bond ETF USD Dist | LQDA | Biotechnology | 37.31 | 3.15B | -0.40% | n/a | 4.70% |
| Travere Therapeutics Inc. | TVTX | Biotechnology | 40.5 | 3.10B | -0.78% | n/a | 2662.08% |
| Kiniksa Pharmaceuticals Ltd | KNSA | Biotechnology | 42.79 | 3.05B | -0.60% | n/a | 2.62% |
| Denali Therapeutics Inc | DNLI | Biotechnology | 19.87 | 2.84B | 2.16% | n/a | 3.51% |
| TNGX | TNGX | Biotechnology | 25.77 | 2.76B | -0.39% | n/a | 15.28% |
| STROUDS INC | STRO | Biotechnology | 33.33 | 2.73B | -4.31% | n/a | 125.14% |
| ARCUTIS BIOTHERAPEUTICS INC. | ARQT | Biotechnology | 23.26 | 2.72B | 1.75% | n/a | 111.34% |
| NewAmsterdam Pharma Company N.V. Ordinary Shares | NAMS | Biotechnology | 29.72 | 2.68B | -5.53% | n/a | 0.15% |
| Veracyte Inc | VCYT | Biotechnology | 34.33 | 2.64B | 3.56% | n/a | 1.83% |
| ADMA Biologics Inc | ADMA | Biotechnology | 11.26 | 2.62B | 1.62% | 112.71 | 75.10% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| LCI Industries | LCII | Recreational Vehicles | 120.01 | 3.06B | -0.45% | 25.82 | 77.66% |
| Harley-Davidson Inc | HOG | Recreational Vehicles | 23.11 | 3.04B | -1.15% | 7.33 | 218.58% |
| Pitney Bowes Inc | PBI | Building Products & Equipment | 15.58 | 2.80B | 1.37% | n/a | -571.93% |
| HNI Corporation | HNI | Building Products & Equipment | 37.7 | 1.78B | 1.32% | 22.12 | 76.47% |
| ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 14.6 | 1.46B | 3.03% | n/a | 19.46% |
| Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 39.11 | 1.23B | -1.21% | 51.60 | 88.92% |
| Winnebago Industries Inc | WGO | Recreational Vehicles | 32.87 | 951.75M | 0.70% | 22.53 | 56.33% |
| Janus International Group Inc. | JBI | Building Products & Equipment | 5.44 | 790.55M | 1.30% | 11.62 | 116.21% |
| Fox Factory Holding Corp | FOXF | Recreational Vehicles | 17.7 | 737.79M | 2.31% | 42.05 | 64.69% |
| Latham Group Inc. | SWIM | Building Products & Equipment | 6.01 | 694.62M | -0.17% | 65.18 | 77.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.60 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 6.52 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 44.09 | - | Lower Risk |
| Debt to Equity | 0.01 | -1.23 | Expensive |
| Debt to Assets | 0.01 | 0.25 | Cheaper |
| Market Cap | 2.96B | - | Par |